Download PDF
Pharmacopsychiatry 2012; 45(S 01): S12-S21
DOI: 10.1055/s-0032-1309002
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Psychiatric Systems Medicine: Closer at Hand than Anticipated but not with the Expected Portrait

F. Iris
1   Bio-Modeling Systems, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
07 May 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Almost all complex human diseases are context-dependent entities to which molecular components make a necessary, but only partial, contribution. This is particularly evident in psychiatric conditions such as schizophrenia and major depressive disorders. Here, classical analytical approaches based on reductionism lead to profound misconceptions of the actual nature of the problem. Consequently, a systems perspective may be the optimal method for approaching complex psychiatric diseases. However, attempting to productively apply systems principles to complex medical conditions is much more difficult than hitherto anticipated. Living systems are integrative and non-linear by nature and embody higher level functional principles that are not reducible to the molecular level. Furthermore, whereas systems biology functions on the basis of large data sets arising from highly targeted investigations upon homogeneous experimental material, systems medicine must proceed on the basis of existing, highly heterogeneous data. The challenge is therefore to assimilate a large, and often conflicting corpus of data to build and inform a systems-level model of the physiological alterations underlying the disorders while reaching beyond somatism (bottom-up approaches), which is provably largely insufficient to functionally explain multicellular living systems to a degree enabling informed therapeutic intervention. This paper factually documents how a modelling approach based on a combination of heuristics (top-down) and algorithmic (bottom-up) modelling strategies, together with the active participation of clinician networks can provide an effective roadmap to productively address psychiatric disorders at large, and schizophrenia in particular.

Key words

systems medicine - heuristic modelling - psychiatry - schizophrenia - neurodegenerative disorders - gap junctions
 

  • References

  • 1 Meisel ZF, Karlawish J. Narrative vs evidence-based medicine – and, not or. JAMA 2011; 306: 2022-2023
    CrossrefPubMedGoogle Scholar
  • 2 Villoslada P, Steinman L, Baranzini SE. Systems biology and its application to the understanding of neurological diseases. Ann Neurol 2009; 65: 124-139
    CrossrefPubMedGoogle Scholar
  • 3 Majumder D, Mukherjee A. A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. Analyst 2011; 136: 663-678
    CrossrefPubMedGoogle Scholar
  • 4 Weiss AJ, Lipshtat A, Mechanick JI. A systems approach to bone pathophysiology. Ann N Y Acad Sci 2010; 1211: 9-24
    CrossrefPubMedGoogle Scholar
  • 5 Nolte T, Guiney J, Fonagy P et al. Interpersonal stress regulation and the development of anxiety disorders: an attachment-based developmental framework. Front Behav Neurosci 2011; 5: 55
    PubMedGoogle Scholar
  • 6 Sweet RA, Fish KN, Lewis DA. Mapping synaptic pathology within cerebral cortical circuits in subjects with schizophrenia. Front Hum Neurosci 2010; 4: 44
    PubMedGoogle Scholar
  • 7 Schroeter ML, Abdul-Khaliq H, Sacher J et al. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol 2010; 2010: 780645
    PubMedGoogle Scholar
  • 8 Liljenstrom H. Network effects of synaptic modifications. Pharmacopsychiatry 2010; 43 (Suppl. 01) S67-S81
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Hauber W. Dopamine release in the prefrontal cortex and striatum: temporal and behavioural aspects. Pharmacopsychiatry 2010; 43 (Suppl. 01) S32-S41
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Ben Achour S, Pascual O. Glia: the many ways to modulate synaptic plasticity. Neurochem Int 2010; 57 (Suppl. 04) 440-445
    CrossrefPubMedGoogle Scholar
  • 11 Fellin T. Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity. J Neurochem 2009; 108: 533-544
    CrossrefPubMedGoogle Scholar
  • 12 Halassa MM, Fellin T, Haydon PG. Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 2009; 57: 343-346
    CrossrefPubMedGoogle Scholar
  • 13 Girardet C, Blanchard MP, Ferracci G et al. Daily changes in synaptic innervation of VIP neurons in the rat suprachiasmatic nucleus: contribution of glutamatergic afferents. Eur J Neurosci 2010; 31: 359-370
    CrossrefPubMedGoogle Scholar
  • 14 Bosler O, Girardet C, Sage-Ciocca D et al. Mechanisms of structural plasticity associated with photic synchronization of the circadian clock within the suprachiasmatic nucleus. J Soc Biol 2009; 203: 49-63
    CrossrefPubMedGoogle Scholar
  • 15 Mitterauer BJ. The syncytiopathy hypothesis of depression: downregulation of glial connexins may protract synaptic information processing and cause memory impairment. Med Hypotheses 2010; 74: 497-502
    CrossrefPubMedGoogle Scholar
  • 16 McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 2008; 13: 501-510
    CrossrefPubMedGoogle Scholar
  • 17 Lee Y, Gaskins D, Anand A et al. Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology (Berl) 2007; 191: 55-65
    CrossrefPubMedGoogle Scholar
  • 18 De Keyser J, Mostert JP, Koch MW. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 2008; 267: 3-16
    CrossrefPubMedGoogle Scholar
  • 19 Silver RA. Neuronal arithmetic. Nat Rev Neurosci 2010; 11: 474-489
    CrossrefPubMedGoogle Scholar
  • 20 England PM. Bridging the gaps between synapses, circuits, and behavior. Chem Biol 2010; 17: 607-615
    CrossrefPubMedGoogle Scholar
  • 21 Schipke CG, Heuser I, Peters O. Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J Psychiatr Res 2011; 45 (Suppl. 02) 242-248
    CrossrefPubMedGoogle Scholar
  • 22 Martins-De-Souza D, Dias-Neto E, Schmitt A et al. Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry 2010; 11: 110-120
    CrossrefPubMedGoogle Scholar
  • 23 Walter M, Henning A, Grimm S et al. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry 2009; 66: 478-486
    CrossrefPubMedGoogle Scholar
  • 24 Turck CW, Iris F. Proteome-based pathway modelling of psychiatric disorders. Pharmacopsychiatry 2011; 44 (Suppl. 01) S54-S61
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Huang S, Wikswo J. Dimensions of systems biology. Rev Physiol Biochem Pharmacol 2006; 157: 81-104
    PubMedGoogle Scholar
  • 26 Ahn AC, Tewari M, Poon CS et al. The clinical applications of a systems approach. PLoS Med 2006; 3: e209
    CrossrefPubMedGoogle Scholar
  • 27 Liebal UW, Millat T, De Jong IG et al. How mathematical modelling elucidates signalling in Bacillus subtilis. Mol Microbiol 2010; 77: 1083-1095
    CrossrefPubMedGoogle Scholar
  • 28 Geier F, Timmer J, Fleck C. Reconstructing gene-regulatory networks from time series, knock-out data, and prior knowledge. BMC Syst Biol 2007; 1: 11
    CrossrefPubMedGoogle Scholar
  • 29 Gadal F, Starzec A, Bozic C et al. Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells. J Mol Endocrinol 2005; 34: 61-75
    CrossrefPubMedGoogle Scholar
  • 30 Gadal F, Bozic C, Pillot-Brochet C et al. Integrated transcriptome analysis of the cellular mechanisms associated with Ha-ras-dependent malignant transformation of the human breast epithelial MCF7 cell line. Nucleic Acids Res 2003; 31: 5789-5804
    CrossrefPubMedGoogle Scholar
  • 31 Rosslenbroich B. Outline of a concept for organismic systems biology. Semin Cancer Biol 2011; 21: 156-164
    CrossrefPubMedGoogle Scholar
  • 32 Drack M, Wolkenhauer O. System approaches of Weiss and Bertalanffy and their relevance for systems biology today. Semin Cancer Biol 2011; 21: 150-155
    CrossrefPubMedGoogle Scholar
  • 33 Mesarovic MD, Sreenath SN, Keene JD. Search for organising principles: understanding in systems biology. Syst Biol (Stevenage) 2004; 1: 19-27
    CrossrefPubMedGoogle Scholar
  • 34 Wolkenhauer O, Mesarovic M, Wellstead P. A plea for more theory in molecular biology. Ernst Schering Res Found Workshop 2007; 117-137
    PubMedGoogle Scholar
  • 35 Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129-136
    CrossrefPubMedGoogle Scholar
  • 36 McGirr EM. Reflections on the principle of life, medical theory and ethics, and the limitations of science. Scott Med J 1994; 39: 150-151
    PubMedGoogle Scholar
  • 37 Drack M, Apfalter W, Pouvreau D. On the making of a system theory of life: Paul A Weiss and Ludwig von Bertalanffy’s conceptual connection. Q Rev Biol 2007; 82: 349-373
    CrossrefPubMedGoogle Scholar
  • 38 Alonso Y. The biopsychosocial model in medical research: the evolution of the health concept over the last two decades. Patient Educ Couns 2004; 53: 239-244
    CrossrefPubMedGoogle Scholar
  • 39 Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci 2011; 14: 1398-1405
    CrossrefPubMedGoogle Scholar
  • 40 Hwang D, Lee IY, Yoo H et al. A systems approach to prion disease. Mol Syst Biol 2009; 5: 252
    PubMedGoogle Scholar
  • 41 Iris F, Gea M, Lampe PH et al. Production and implementation of predictive biological models. Med Sci (Paris) 2009; 25: 608-616
    PubMedGoogle Scholar
  • 42 Pouillot F, Blois H, Iris F. Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria. Biosecur Bioterror 2010; 8: 155-169
    CrossrefPubMedGoogle Scholar
  • 43 Wirths O, Bayer TA. Motor impairment in Alzheimer’s disease and transgenic Alzheimer’s disease mouse models. Genes Brain Behav 2008; 7 (Suppl. 01) 1-5
    CrossrefPubMedGoogle Scholar
  • 44 Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3: 11-40
    CrossrefPubMedGoogle Scholar
  • 45 Mallucci GR, White MD, Farmer M et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53: 325-335
    CrossrefPubMedGoogle Scholar
  • 46 Kielian T. Glial connexins and gap junctions in CNS inflammation and disease. J Neurochem 2008; 106 (Suppl. 03) 1000-1016
    CrossrefPubMedGoogle Scholar
  • 47 Altevogt BM, Paul DL. Four classes of intercellular channels between glial cells in the CNS. J Neurosci 2004; 24: 4313-4323
    CrossrefPubMedGoogle Scholar
  • 48 Saez JC, Retamal MA, Basilio D et al. Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 2005; 1711: 215-224
    CrossrefPubMedGoogle Scholar
  • 49 Evans WH, De Vuyst E, Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J 2006; 397: 1-14
    CrossrefPubMedGoogle Scholar
  • 50 Pascual O, Casper KB, Kubera C et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005; 310: 113-116
    CrossrefPubMedGoogle Scholar
  • 51 Eid T, Williamson A, Lee TS et al. Glutamate and astrocytes – key players in human mesial temporal lobe epilepsy?. Epilepsia 2008; 49 (Suppl. 02) 42-52
    PubMedGoogle Scholar
  • 52 Carmignoto G, Fellin T. Glutamate release from astrocytes as a non-synaptic mechanism for neuronal synchronization in the hippocampus. J Physiol Paris 2006; 99: 98-102
    CrossrefPubMedGoogle Scholar
  • 53 Gigout S, Louvel J, Kawasaki H et al. Effects of gap junction blockers on human neocortical synchronization. Neurobiol Dis 2006; 22: 496-508
    CrossrefPubMedGoogle Scholar
  • 54 Jermakowicz WJ, Casagrande VA. Neural networks a century after Cajal. Brain Res Rev 2007; 55: 264-284
    CrossrefPubMedGoogle Scholar
  • 55 Rossetti AO, Dunand M. Creutzfeldt-Jakob disease: evolution from nonconvulsive status epilepticus, through SIRPIDs, to generalized periodic discharges. Clin Neurophysiol 2007; 118: 2533-2536
    CrossrefPubMedGoogle Scholar
  • 56 Ishida C, Okino S, Kitamoto T et al. Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2005; 76: 325-329
    CrossrefPubMedGoogle Scholar
  • 57 Bruder GE, Wexler BE, Sage MM et al. Verbal memory in schizophrenia: additional evidence of subtypes having different cognitive deficits. Schizophrenia Res 2004; 68: 137-147
    CrossrefPubMedGoogle Scholar
  • 58 Goodman C, Knoll G, Isakov V et al. Insight into illness in schizophrenia. Comprehensive Psychiatry 2005; 46: 284-290
    CrossrefPubMedGoogle Scholar
  • 59 Reilly JL, Harris MS, Khine TT et al. Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry 2007; 62 (Suppl. 07) 818-821
    CrossrefPubMedGoogle Scholar
  • 60 Vogeley K, Kupke C. Disturbances of time consciousness from a phenomenological and a neuroscientific perspective. Schizophrenia Bull 2007; 33: 157-165
    PubMedGoogle Scholar
  • 61 Piskulic D, Olver JS, Norman TR et al. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res 2007; 150: 111-121
    CrossrefPubMedGoogle Scholar
  • 62 Pantelis C, Barnes TR, Nelson HE et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997; 120 (Pt 10) 1823-1843
    CrossrefPubMedGoogle Scholar
  • 63 Badcock JC, Michiel PT, Rock D. Spatial working memory and planning ability: contrasts between schizophrenia and bipolar I disorder. Cortex 2005; 41: 753-763
    CrossrefPubMedGoogle Scholar
  • 64 Pirkola T, Tuulio-Henriksson A, Glahn D et al. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol Psychiatry 2005; 58: 930-936
    CrossrefPubMedGoogle Scholar
  • 65 Glahn DC, Bearden CE, Cakir S et al. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disorders 2006; 8: 117-123
    CrossrefPubMedGoogle Scholar
  • 66 Laroche S, Davis S, Jay TM. Plasticity at hippocampal to prefrontal cortex synapses: dual roles in working memory and consolidation. Hippocampus 2000; 10: 438-446
    CrossrefPubMedGoogle Scholar
  • 67 Izaki Y, Takita M, Nomura M. Local properties of CA1 region in hippocampo-prefrontal synaptic plasticity in rats. Neuroreport 2002; 13: 469-472
    CrossrefPubMedGoogle Scholar
  • 68 Jay TM, Rocher C, Hotte M et al. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotoxicity Res 2004; 6: 233-244
    CrossrefPubMedGoogle Scholar
  • 69 Craig S, Commins S. Interaction between paired-pulse facilitation and long-term potentiation in the projection from hippocampal area CA1 to the entorhinal cortex. Neurosci Res 2005; 53: 140-146
    CrossrefPubMedGoogle Scholar
  • 70 Kawashima H, Izaki Y, Grace AA et al. Cooperativity between hippocampal-prefrontal short-term plasticity through associative long-term potentiation. Brain Res 2006; 1109: 37-44
    CrossrefPubMedGoogle Scholar
  • 71 Osipova D, Takashima A, Oostenveld R et al. Theta and gamma oscillations predict encoding and retrieval of declarative memory. J Neurosci 2006; 26: 7523-7531
    CrossrefPubMedGoogle Scholar
  • 72 Sederberg PB, Kahana MJ, Howard MW et al. Theta and gamma oscillations during encoding predict subsequent recall. J Neurosci 2003; 23: 10809-10814
    PubMedGoogle Scholar
  • 73 Vinogradova OS, Kitchigina VF, Zenchenko CI. Pacemaker neurons of the forebrain medical septal area and theta rhythm of the hippocampus. Membr Cell Biol 1998; 11: 715-725
    PubMedGoogle Scholar
  • 74 Watanabe H, Aihara T, Tsukada M. Phase shift of subthreshold theta oscillation in hippocampal CA1 pyramidal cell membrane by excitatory synaptic inputs. Neuroscience 2006; 140: 1189-1199
    CrossrefPubMedGoogle Scholar
  • 75 Rash JE, Yasumura T, Davidson KG et al. Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun Adhes 2001; 8: 315-320
    CrossrefPubMedGoogle Scholar
  • 76 Nagy JI, Li X, Rempel J et al. Connexin26 in adult rodent central nervous system: demonstration at astrocytic gap junctions and colocalization with connexin30 and connexin43. J Comp Neurol 2001; 441: 302-323
    CrossrefPubMedGoogle Scholar
  • 77 Kopell N, Ermentrout GB, Whittington MA et al. Gamma rhythms and beta rhythms have different synchronization properties. Proc Natl Acad Sci USA 2000; 97: 1867-1872
    CrossrefPubMedGoogle Scholar
  • 78 Schnitzler A, Gross J. Normal and pathological oscillatory communication in the brain. Nat Rev Neurosci 2005; 6: 285-296
    PubMedGoogle Scholar
  • 79 von Stein A, Sarnthein J. Different frequencies for different scales of cortical integration: from local gamma to long range alpha/theta synchronization. Int J Psychophysiol 2000; 38: 301-313
    CrossrefPubMedGoogle Scholar
  • 80 Cambridge Healthtech Institute’s “Bio-IT Best Practice Award” 2009 http://www.bio-itworld.com/BioIT_Article.aspx?id=93536
    PubMed
  • 81 Iris F. Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages. 2006 http://www.wipo.int/patentscope/search/en/WO2008093009
    PubMedGoogle Scholar
  • 82 Iris F. Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence. 2006 http://www.wipo.int/patentscope/search/en/WO2008093010
    PubMedGoogle Scholar
  • 83 Pouillot F, Iris F. Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof. 2009 http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010125296&recNum=1&docAn=FR2010050796&queryString=FP:%28WO/2010/125296%20%09%29&maxRec=1
    PubMedGoogle Scholar
  • 84 Mouthon F, Charveriat M, Deslys J-P et al. Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs. 2008 http://www.wipo.int/patentscope/search/en/WO2010029131
    PubMedGoogle Scholar
  • 85 European Commission . DG Research, Directorate of Health. From Systems Biology to Systems Medicine 2010; 5-6 ftp://ftp.cordis.europa.eu/pub/fp7/health/docs/final-report-systems-medicine-workshop_en.pdf
    PubMedGoogle Scholar